BlueRock Therapeutics
company
About
It is a regenerative medicine company.
- 101 - 250
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $225M
- Industries
- Biopharma,Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 101 - 250
- Operating Status
- Active
BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. One of the initial programs is to regenerate heart muscle in patients who have had a heart attack (myocard infarction, MI) or are suffering from chronic heart failure, leading causes of morbidity and mortality worldwid.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$225M
BlueRock Therapeutics has raised a total of
$225M
in funding over 2 rounds. Their latest funding was raised on
Dec 12, 2016 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 12, 2016 | Series A | $225M | 2 |
Bayer
Versant Ventures
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
BlueRock Therapeutics has made 1 investments. Their most recent investment was on
Nov 6, 2019, when Digits raised $10.50M.
Investors
Number of Lead Investors
Number of Investors
2
2
BlueRock Therapeutics is funded by 2 investors.
Bayer
and Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Bayer
|
Yes | Series A |
|
Versant Ventures
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
